[Tetracycline lesions of the liver and their treatment (a review of the literature)].
D000818:Animals; D000975:Antioxidants / Q000627:therapeutic use; D001646:Bile / Q000187:drug effects / Q000502:physiology; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D005234:Fatty Liver / Q000139:chemically induced / Q000378:metabolism; D005609:Free Radicals; D006801:Humans; D008054:Lipid Peroxides / Q000378:metabolism; D008099:Liver / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D010084:Oxidation-Reduction / Q000187:drug effects; D010085:Oxidative Phosphorylation / Q000187:drug effects; D010636:Phenols / Q000627:therapeutic use; D020887:Selenious Acid; D012643:Selenium / Q000627:therapeutic use; D013754:Tetracyclines / Q000009:adverse effects* / Q000633:toxicity
D000975:Antioxidants; D005609:Free Radicals; D008054:Lipid Peroxides; D010636:Phenols; D013754:Tetracyclines; D003577:Cytochrome P-450 Enzyme System; D020887:Selenious Acid; D012643:Selenium
Tetratsiklinovye porazheniia pecheni i ikh lechenie (obzor literatury).